Search

everythinglearnresearchcommunity

for

Search:↓

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

JAK inhibitors have therapeutic potential but pose significant risks, requiring careful monitoring.

New information shows Valproate may protect the brain and reduce breathing failure risk but can cause liver damage and other side effects, with genetics affecting dosage needs.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

A woman with a rare scalp infection was cured after one month of medication.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Valproic acid helped hair growth in alopecia patient; more research needed.

Ritlecitinib can help about 14,000 people with severe hair loss.

The combination treatment effectively and safely cured scalp microsporia in children faster and prevented recurrence.

Vemurafenib causes significant skin side effects, requiring regular dermatologist care and sun protection.

Surgical excision is the best treatment for SCC, but intralesional cidofovir might be a good alternative.

ATP helps prevent skin damage from vandetanib by reducing stress.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Griseofulvin effectively treats tinea capitis in infants.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Abatacept may help some people with alopecia areata regrow hair.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Combining ciclosporin and simvastatin can cause severe kidney damage.

Tofacitinib helped regrow hair in a teen with a unique pattern of alopecia areata.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Leflunomide and anthralin may effectively treat severe alopecia areata.